US-based developer of diagnostic products Hologic is showcasing its 3D mammography (breast tomosynthesis) technology platform at the ongoing Arab Health Congress in Dubai.

The leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, will also showcase the Selenia Dimensions 3D mammography system with C-View software.

C-View software allows a 2D image to be constructed from a 3D data set without the need for a separate 2D x-ray exposure.

The C-View software is designed to also offer a reduction in x-ray exposures leading to shorter exam times (less than 4-second scan per view), and increased patient comfort from the shorter compression time.

The company also features its Affirm 3D mammography biopsy option designed for the localisation and accurate targeting of regions of interest including targeting lesions not detected with conventional 2D imaging.

The Affirm system is pre-programmed for use with the company's Eviva and Atec vacuum-assisted breast biopsy devices.

David Harding, group senior VP and general manager, Women’s Health, said: “The congress provides us with the opportunity to highlight our suite of imaging, diagnostic and surgical healthcare solutions.

"In 2013, we opened an office in Dubai strengthening our presence in this strategic region through enhanced customer service and improved sales and marketing support for our regional partners.”

The platform offers superior clinical performance compared to 2D alone, with a 40 per cent improvement in invasive cancer detection, coupled with a 20 to 40 per cent reduction in recall rates.

Hologic is also showcasing two other new commercial products for the first time at Arab Health. Its Selenia Dimensions Avia Package offers a lower-cost option for customers seeking a 2D screening only or 2D screening and diagnostic solution with an upgrade path to future applications such as 3D mammography.

Its Horizon DXA series is designed to offer clinicians expanded technical capabilities, workflow efficiencies and improved design components that assist clinicians in the assessment of critical health problems such as osteoporosis, cardiovascular disease, body composition and atypical femur fractures.

Also on display are the company’s extremity imaging, imaging analytics, GYN surgical and molecular diagnostics products. - TradeArabia News Service